These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6581483)

  • 1. Chemical renal medullectomy and experimental hypertension.
    Russell GI; Bing RF; Taverner D; Swales JD; Thurston H
    Proc Eur Dial Transplant Assoc; 1983; 20():546-50. PubMed ID: 6581483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical renal medullectomy. Effect on urinary prostaglandin E2 and plasma renin in response to variations in sodium intake and in relation to blood pressure.
    Bing RF; Russell GI; Thurston H; Swales JD; Godfrey N; Lazarus Y; Jackson J
    Hypertension; 1983; 5(6):951-7. PubMed ID: 6360871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical renal medullectomy: effect on blood pressure in normal rats.
    Taverner D; Fletcher A; Russell GI; Bing RF; Jackson J; Swales JD; Thurston H
    J Hypertens Suppl; 1983 Dec; 1(2):43-5. PubMed ID: 6599495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasodepressor mechanisms in experimental hypertension: studies using chemical medullectomy.
    Swales JD; Bing RF; Russell GI; Taverner D; Thurston H
    J Hypertens Suppl; 1986 Oct; 4(4):S43-6. PubMed ID: 3534184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension produced by chemical renal medullectomy: evidence for a renomedullary vasodepressor function in the rat.
    Taverner D; Bing RF; Fletcher A; Russell G; Swales JD; Thurston H
    Clin Sci (Lond); 1984 Nov; 67(5):521-8. PubMed ID: 6383693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension produced by chemical renal medullectomy or partial nephrectomy in the rat: comparison of renal function and plasma volume.
    Taverner D; Bing RF; Swales JD; Thurston H
    J Hypertens Suppl; 1984 Dec; 2(3):S367-9. PubMed ID: 6599684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical medullectomy does not prevent sodium retention in nephrotic rats.
    Keeler R
    Miner Electrolyte Metab; 1989; 15(4):241-5. PubMed ID: 2761491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylprednisolone-induced hypertension in the rat: evidence against the role of plasma volume changes, vasopressin and renal prostaglandin E2.
    Ramos-Frendo B; Eloy L; Grünfeld JP
    J Hypertens; 1985 Oct; 3(5):461-7. PubMed ID: 3864857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies on the mechanism of increased blood pressure during dietary linoleic acid deprivation.
    Düsing R; Scherf H; Landsberg G; Glänzer K; Kramer HJ
    Ann Clin Res; 1984; 16 Suppl 43():103-8. PubMed ID: 6442961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 production by renomedullary tissue of DOCA, Goldblatt and spontaneously hypertensive rats.
    Stygles VG; Reinke DA; Hook JB
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):753-65. PubMed ID: 1005918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluid volumes and hemodynamics in hypertension produced by chemical renal medullectomy.
    Taverner D; Bing RF; Swales JD; Thurston H
    Am J Physiol; 1985 Aug; 249(2 Pt 2):H415-20. PubMed ID: 3895983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal vasodepressor mechanism: characterization by chemical medullectomy.
    Swales JD; Bing RF; Edmunds ME; Russell GI
    Am J Med Sci; 1988 Apr; 295(4):241-5. PubMed ID: 3284347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal prostaglandins in relation to sodium regulation and hypertension.
    Tobian L; O'Donnell M
    Fed Proc; 1976 Oct; 35(12):2388-92. PubMed ID: 964389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical renal medullectomy; effect upon reversal of two-kidney, one-clip hypertension in the rat.
    Bing RF; Russell GI; Swales JD; Thurston H; Fletcher A
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():335s-338s. PubMed ID: 7318335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vasodepressor function of the kidney: prostaglandin E2 is not the principal vasodepressor lipid of the renal medulla.
    Glodny B; Pauli GF
    Acta Physiol (Oxf); 2006 Jul; 187(3):419-30. PubMed ID: 16776667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of renal papillary-medullary lesion on the antihypertensive effect of furosemide and development of salt-sensitive hypertension in Dahl-S rats.
    Haugan K; Shalmi M; Petersen JS; Marcussen N; Spannow J; Christensen S
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1415-22. PubMed ID: 9067331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the renal medulla in experimental hypertension.
    Russell GI; Taverner D; Jackson J; Bing RF; Swales JD; Thurston H
    Contrib Nephrol; 1984; 41():163-6. PubMed ID: 6597069
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of the adrenal medulla in control of blood pressure and renal function during frusemide-induced volume depletion.
    Hasbak P; Petersen JS; Shalmi M; Lam HR; Christensen NJ; Christensen S
    J Hypertens; 1995 Feb; 13(2):235-42. PubMed ID: 7615954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renal concentrating defect after gentamicin administration in the rat.
    Gordon JA; Dillingham MA; Guggenheim SJ; Grossfeld PD; Anderson RJ
    J Lab Clin Med; 1983 Jun; 101(6):903-10. PubMed ID: 6574196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal prostaglandins in borderline and sustained essential hypertension.
    Lebel M; Grose JH
    Prostaglandins Leukot Med; 1982 May; 8(5):409-18. PubMed ID: 7048332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.